Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aerosolized Isotretinoin and Antifungals for Severe COVID-19
NCT04577378Phase 2Unknown
- Sponsor
- Kafrelsheikh University
- Start
- Oct 2020
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of isotretinoin in coronavirus disease 2019 (COVID-19) (3 arms), sponsored by Kafrelsheikh University. Primary endpoint: Lung Injury Score at 14 days. Status: unknown.
02
Drugs
isotretinoin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04577378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04577378.